Minister of State for Health Shripad Yesso Naik said the government is working to have an independent drug controller for the Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH), separated from the drug controller of modern medicine.
"The Ministry of AYUSH has asked the Finance Ministry to hike the budgetary allocation for propagation and promotion of AYUSH to an extent of Rs 2,700 crore for fiscal 2015-16 from the present level of Rs 400 crore," a PHD Chamber of Commerce and Industry statement said, quoting Naik.
The Department of AYUSH aims at providing attention to development of education and research in Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy systems.
The Health Ministry budget is likely to face a massive Rs 6,000-crore cut on account of non-utilisation of the entire budgetary allocation even as its Minister J P Nadda had recently maintained that no flagship programme will be affected due to the cut.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
